Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction

Affiliations

¹ Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
² Clinical Neuroscience Research Unit, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Review

Robert E McCullumsmith et al. Neuropsychopharmacology. 2015 Jan.

. 2015 Jan;40(1):254-5.

doi: 10.1038/npp.2014.218.

¹ Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
² Clinical Neuroscience Research Unit, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

No abstract available

References

1. Karlsson RM, Tanaka K, Saksida LM, Bussey TJ, Heilig M, Holmes A (2009). Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology 34: 1578–1589. - PMC - PubMed
1. Lee A, Pow DV (2010). Astrocytes: glutamate transport and alternate splicing of transporters. Int J Biochem Cell Biol 42: 1901–1906. - PubMed
1. Sanacora G, Banasr M (2013). From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 73: 1172–1179. - PMC - PubMed
1. Shan D, Yates S, Roberts RC, McCullumsmith RE (2012). Update on the neurobiology of schizophrenia: a role for extracellular microdomains. Minerva Psichiatr 53: 233–249. - PMC - PubMed
1. Shen HW, Scofield MD, Boger H, Hensley M, Kalivas PW (2014). Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci 34: 5649–5657. - PMC - PubMed